| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |